Speaker Biographies

Filter by:

Clear Filters
HealthTech for Medicaid (HT4M)

Adimika Arthur, Executive Director, HealthTech for Medicaid (HT4M)

Adimika Arthur is Executive Director at HealthTech for Medicaid (HT4M), a nascent national nonprofit dedicated to increasing the rate of innovation in the Medicaid space. Mrs. Arthur has more than twenty years of experience in the industry, including as a clinical epidemiologist in county-level leadership, an executive in integrated hospital delivery systems, and author of the 2005 California Medicaid 1115 waiver to expand coverage in Alameda County (7th largest county in CA). Adimika has spent her career dedicated to the Medicaid population, most recently serving as the Director of Clinical Operations at Sutter Health. She has also previously served as a Service Line Director at the University of California at San Francisco Medical Center/UCSF Benioff Children’s Hospital and Alameda County Medical Center, both public hospitals in California. She also runs a management consultancy company focusing on health system clients. She has an MPH from the University of Washington, and a BS from Clark Atlanta University.

Civitas Networks for Health

Lisa Bari, CEO, Civitas Networks for Health

Lisa Bari is the CEO of Civitas Networks for Health, the national nonprofit organization with a mission to support community and data-led health improvement and information exchange to address health outcomes and provide the infrastructure for health equity. Civitas Networks for Health counts more than 180 regional health improvement collaboratives, regional and statewide health information exchanges, and affiliated organizations as members. Lisa previously served as the interim CEO of the Strategic Health Information Exchange Collaborative, the health IT and interoperability lead at the CMS Innovation Center working on primary care payment models, and earlier in her career, part of the executive leadership team of an electronic health records company. She holds an MBA from Purdue University and an MPH in Health Policy from the Harvard T.H. Chan School of Public Health. Learn more about Civitas Networks for Health at www.civitasforhealth.org, and learn more about Lisa at www.lisabari.com.

Health Velocity Capital

Saurabh Bhansali, Co-Founder and Managing Partner, Health Velocity Capital

Saurabh has spent his career working with innovative healthcare services and software companies. Prior to co-founding Health Velocity Capital, Saurabh helped build and lead investments for Humana Health Ventures, the venture capital arm at one of the nation’s leading healthcare companies and second largest Medicare Advantage insurer. Prior to Humana, Saurabh was on the investing team at HLM Venture Partners, where he was involved in investments in Binary Fountain (acq. by Press Ganey), ClearDATA Networks, and AbleTo (acq. by Optum) and served as a Board Observer at Vericare Management (acq. by MedOptions) and Imagine Health (acq. by ELAP) . He also held roles at Peloton Equity as part of the investing team, at Bank of America Merrill Lynch as an investment banker, and at Pfizer as part of the mergers, acquisitions and licensing team. Saurabh serves on the board of HealthJoy, Octave, Torch Dental and Zipari and serves as a board observer at Headspace Health and Spero Health. His prior investments include Aspire Health (acq. by Anthem), Circulation Health (acq. by Logisticare), Livongo Health (acq. by Teladoc Health) and Omada Health. He received his BA from Northwestern University and his MBA from The Wharton School at the University of Pennsylvania.

Maverick Ventures

Ambar Bhattacharyya, Managing Director, Maverick Ventures

Ambar Bhattacharyya is a Managing Director at Maverick Ventures, a venture capital fund based in San Francisco. Prior to joining Maverick, he spent his career at Bessemer Venture Partners, Bain Capital Ventures, MinuteClinic, and Bain & Company. Ambar holds an M.B.A. with distinction from Harvard Business School and a B.S. in economics and a B.A. in psychology from the University of Pennsylvania. He serves as an advisor to the California Healthcare Foundation Innovation Fund. Ambar has received broad recognition for his leadership, including being selected to be on Fortune's "40 Under 40" list, Business Insider’s “30 leaders under 40 transforming healthcare”, and as a Global Shaper by the World Economic Forum.


Christine Brocato, System Vice President, Strategic Innovation, CommonSpirit Health

Christine Brocato is the System VP of Strategic Innovation at CommonSpirit Health, the parent company of Dignity Health and Catholic Health Initiatives. In close partnership with operational leaders , Christine co-leads innovation projects related to care automation, behavioral health, transportation, population health, and ambulatory care transformation. Christine is passionate about helping vulnerable and Medicaid populations receive access to patient- centered care and access to social resources that prevent health disparities. She has more than 15 years of healthcare management experience, with leadership roles that shaped business strategy, corporate development initiatives and product roadmaps at Genentech, Abbott Vascular, and Kaiser Permanente. Christine has an MBA from Georgetown University and Bachelors of Science in Combined Sciences from Santa Clara University. Christine lives in the Bay Area with her husband and two daughters. In her free time, she advocates for closing the digital divide for Oakland’s youth as an active Board Member of TechExchange.

California Health Care Foundation

Melissa Buckley, Director, Health Innovation Fund, California Healthcare Foundation

Melissa Buckley directs the California Health Care Foundation (CHCF) Health Innovation Fund. In addition to having deep experience at the intersection of health care and finance, she leads one of the nation's first investment funds to exist within a philanthropic foundation and one of the first funds to focus exclusively on the Medicaid market. The CHCF Innovation Fund has invested in 25 venture-backed companies working in the Medicaid market since its founding 2011. With the Fund's strategic support, which typically includes introducing companies to payers and providers, leading third-party evaluations, and navigating regulatory challenges, one investee, iRhythm, has gone public and others, including Collective Medical, Unite US, Omada, Propeller, and Landmark Health, have reached significant scale. Because the Fund is part of a philanthropic foundation, it has a uniquely mission-driven focus and keen ability to identify innovations that will truly improve care.

Define Ventures

Lynne Chou O'Keefe, Founder & Managing Partner, Define Ventures

Lynne Chou O’Keefe is the Founder and Managing Partner of Define Ventures, an early stage venture capital firm focused on investing in digital health companies redefining healthcare. Define Ventures focuses on incubation, seed, Series A, and Series B stage digital health startups (www.definevc.com). Lynne has partnered with entrepreneurs to help them build category defining digital health companies, such as Livongo (NASDAQ:LVGO), HIMS (NASDAQ:HIMS), Unite Us etc. Previous to Define Ventures, Lynne’s experience includes both healthcare operating, investing, and finance roles. Previously, she was a Senior Partner at Kleiner Perkins focused on digital health and connected devices early stage investing. Before joining Kleiner Perkins, Lynne worked at Abbott Vascular and Guidant in multiple roles launching over ten product families in the US and internationally. Lynne was responsible for building the global commercial strategy and therapy development as well as playing a key role in the clinical, reimbursement, and operational strategy for these therapies. Earlier in her career, Lynne worked at Apax Partners with a focus on software venture capital investing. In addition, Lynne worked at Goldman Sachs in the Mergers and Acquisitions group and worked on multiple multi-billion dollar acquisitions and sell side transactions in various industries. Lynne has been named WSJ’s Women in Venture Capital to Watch in 2020. Lynne earned a Bachelor of Science degree in Industrial Engineering from Stanford University and an M.B.A. from Harvard Business School.

Jessica Clark, Senior Vice President, Risk Adjustment and Stars and Quality, Humana

Jessica Clark is the Senior Vice President of Healthcare Quality Reporting and Improvement (HQRI). Jessica’s responsibilities include the enterprise strategy to achieve excellence in the measures impacting the Centers for Medicare & Medicaid Services’ (CMS) Stars Ratings, and she leads Medicare Risk Adjustment operations accounting for the overall health and expected medical costs of members. She also leads the enterprise strategy around interoperability and connections with EHRs.

Silicon Valley Bank

Brandon helps spearhead HealthTech efforts, geographically working with companies in the San Francisco Bay Area, the Pacific Northwest and Western Canada. During his 9+ years at SVB, Brandon has worked with companies across HealthTech, synthetic biology, diagnostics, biopharma and software, ranging from brand-new startups to global public companies. Brandon holds a bachelor’s in economics and political science from San Diego State University.

UpStream Care

Sanjay Doddamani, MD, Co-Founder & CEO, UpStream

Dr. Sanjay Doddamani is the chief executive officer at UpStream, a global risk organization with a unique model of integrated team-based care, clinical and retail pharmacy programs, and two-sided risk bearing capabilities for primary care physicians to be successful in value-based care. Prior to joining UpStream, he was executive vice president, chief physician executive and chief operating officer at Southwestern’s accountable care network, where he oversaw the strategy and implementation of operations, quality, clinical programs, and population health. In 2019, he served in the federal government as a senior physician advisor at the Center for Medicare and Medicaid Innovation (CMMI) within the Centers for Medicare and Medicaid Services - working with teams on alternate payment models that test and measure value-based payment innovation. Prior to joining CMMI, he was Chief Medical Officer of Geisinger at Home, a home-based model of care for medically complex patients, and concurrently, led the Keystone ACO. He continues to focus on accelerating the transition to value based care, improving patient outcomes, and harnessing big data and artificial intelligence to empower clinicians to provide better care. Dr. Doddamani is a clinical cardiologist who is board certified in internal medicine and cardiology. He continues to serve on several panels and advisory committees that address many of the healthcare challenges facing our nation.

Flare Capital Partners

Daniel G. Gebremedhin, MD, Partner, Flare Capital Partners

Dan Gebremedhin is a Partner at Flare Capital Partners and serves on the Board of Flare portfolio companies Eden Health and Somatus. Prior to joining Flare Capital, Dan served as a Medical Director at the Harvard Pilgrim Health Plan. Dan spent over 8 years as a practicing Internal Medicine Physician at the Massachusetts General Hospital and Instructor in Medicine at Harvard Medical School, after completing Internal Medicine Residency at the Massachusetts General Hospital in 2010. He has served as a Health Policy Advisor for Massachusetts Governor Charlie Baker and currently sits on the Massachusetts State Board of Nursing Home Administrators. Dan earned a BS from the University of California, San Diego, an MD from the Morehouse School of Medicine, and an MBA from the Harvard Business School.

Reimagine Care

Aaron Gerber, MD, Co-Founder & CEO, Reimagine Care

Aaron Gerber, MD, has more than 25 years of experience working with a broad set of healthcare organizations as a senior executive, management consultant, and private equity investor. Prior to co-founding Reimagine Care, Dr. Gerber was President Sg2, Advisory Solutions and Member Connections for Vizient, Inc. where he had responsibility for a portfolio of five businesses representing more than 800 individuals and $110 million in contribution margin. Prior to Sg2/Vizient, Aaron held roles as a Partner at Oliver Wyman, SVP of Strategy and Business Development for Vanguard Health Chicago, and Co-founder and CEO of an executive health and wellness company that was sold to Northwestern Memorial Hospital. Dr. Gerber started his postgraduate business career at McKinsey & Company after receiving his MD and MBA from Northwestern University.

Longitude Capital

Gregory Grunberg, PhD, Managing Director, Longitude Capital

Dr. Gregory Grunberg is a Managing Director at Longitude Capital. Prior to joining Longitude Capital in 2012, Dr. Grunberg was a Principal at Rho Ventures and an Engagement Manager at McKinsey & Company. Dr. Grunberg is a board-certified physician in Internal Medicine and completed his residency at Cornell’s New York-Presbyterian Hospital. He has maintained a limited clinical practice in Internal Medicine, including current and previous affiliations with UCSF, Kaiser Permanente, Cornell, and Montefiore. Dr. Grunberg currently serves on the boards of 89bio (ETNB), On Belay, Somatus, Sydnexis, and WelbeHealth. He is also a board observer at Cohere Health and Cortica. He previously served on the board of California Cryobank (acquired by GI Partners and now known as Generate Life Sciences) and Kala Pharmaceuticals (KALA) and led Longitude’s investment in Practice Fusion (acquired by Allscripts). While at Rho Ventures, he served on the board of AqueSys (acquired by Allergan) and was a board observer at both SARCode Bioscience (acquired by Shire) and PHT (acquired by ERT). Dr. Grunberg holds an MD and an MBA from Duke University, where he was a Fuqua Scholar, and an BA in Economics and English from Amherst College.

Anna Haghgooie, Managing Director, Valtruis, Welsh, Carson, Anderson & Stow (WCAS)

Anna Haghgooie is a Managing Director at Valtruis, a Welsh, Carson, Anderson & Stow (WCAS) company and an Operating Partner at WCAS. Valtruis, is a unique platform that invests in and partners with disruptive leaders whose mission is to align and transform healthcare through value-based care. Valtruis is investing +$600M into companies and building portfolio support capabilities to help our companies take on and manage risk at scale. Previously, Anna was a Managing Director of the Blue Venture Fund and Sandbox Industries. The Blue Venture Fund is a unique collaboration between BCBS companies, BCBSA, and Sandbox, where she managed over $900M in capital across four funds. Anna currently serves on the boards of Wayspring, InStride Health, Oncology Care Partners, and TailorCare. She previously served on the boards of Contessa, PWN Health, ExactCare, naviHealth, Change Healthcare, Quilted Health, Somatus, ZeOmega, and SonarMD. Anna earned a bachelor’s degree from the University of Michigan and a MBA with honors from the University of Chicago Booth School of Business. Anna is a Fellow in the Health Innovators Fellowship at the Aspen Institute and lives in Chicago, IL with her husband and two children.

Camilla Hermann, Co-Founder and CEO, Oath Care

Camilla Hermann is Co-founder and CEO of Oath Care, a startup on a mission to elevate the experience of motherhood by combining community support with medical expertise. Oath's digital app supports the entire journey, starting in fertility and pregnancy, through early childhood. Prior to Oath, Camilla developed contact tracing technology to scale the capacity of doctors during the Ebola epidemic in West Africa. She additionally built a chat-based telemedicine product for private practice physicians in the US. Her work has been featured by CBS News, Harvard University, Huffington Post.

United Healthcare Community & State

Jenny Ismert, Senior Vice President of Strategy Operations, UnitedHealthcare Community & State

Jenny Ismert is the Senior Vice President of Strategy in the Medicaid business for UnitedHealthcare. UnitedHealthcare Community & State proudly serves nearly six million Medicaid members, including more than 2.7 million children, in 31 states, plus Washington D.C. UnitedHealthcare is a division of UnitedHealth Group (NYSE: UNH) which is a diversified health and well-being company with a mission to help people live healthier lives and help make the health system work better for everyone. UnitedHealthcare Community & State leverages the national capabilities of UnitedHealth Group and delivers them at the local market level to support effective care management, strong regulatory partnerships, greater administrative efficiency, improved clinical outcomes, and the ability to adapt to a changing market environment. As Senior Vice President of Strategy, Jenny leads innovation, mergers and acquisitions, and working across the UnitedHealth Group enterprise on digital and technology advancements to help make the health care system work better for everyone. Prior to serving as Senior Vice President of Strategy, Jenny held a number of leadership positions with UnitedHealthcare Community & State, including Vice President of Innovation, Vice President of Policy and Strategic Engagement and Vice President of Housing. Combined, Jenny has more than 20 years of experience in the health care industry with the vast majority of her career focused on Medicaid. Jenny earned her Bachelor’s of Science degree in Biology at the University of North Texas, and a Master’s of Business Administration, with a major in Health Administration, from the University of Colorado at Denver, Colorado. For more information about UnitedHealthcare, visit www.uhc.com, or follow @myUHC on Twitter and join the conversation on our UnitedHealthcare Community Plan Facebook page.

Inbound Health

Dave Kerwar, Founder & CEO, Inbound Health

Dave Kerwar is the founding CEO of Inbound Health where he partners with his leadership team to oversee all aspects of the company’s clinical, growth, operational, and product initiatives. Dave has held leadership roles at leading firms across the healthcare ecosystem and has executed leading-edge strategies to improve care quality, reduce cost, and create consumer-centricity in healthcare. Prior to Inbound, Dave was the Chief Product Officer at Mount Sinai Health System, where he built and oversaw a technology-enabled operation to drive Mount Sinai’s Consumer, Direct-to-Employer, and Population Health businesses. Previously, Dave was the Head of Joint Venture Business Development at Aetna where he designed and sourced Aetna’s JVs with large health systems across the US to develop provider-led health insurance products. Earlier in his career, Dave held leadership roles at TriZetto an was an early team member at Broadlane. Dave holds a BA in Computer Science from Hamilton College and an MBA in Healthcare Management and Finance from The Wharton School.

Cambridge Innovation Institute

Benjamin Lakin, PhD, President, Cambridge Innovation Institute

Ben leads the innovation and technology team at Cambridge Innovation Institute (CII) to usher in new products, strategies, software, and work-flow improvements. He has been with CII since 2018. Prior to joining CII, Ben worked as a Scientist at Smith & Nephew, where he helped launch several bioresorbable implants to repair knee, hip and shoulder pathologies, and he also led the development and characterization of new polymers/biocomposites and wearables for enhanced healing. Ben received his BS in Mechanical Engineering from the University of Maine, worked as a Process Engineer for Procter & Gamble, and then earned his MS and PhD in Biomedical Engineering from Boston University. He has authored over 10 peer-reviewed publications and delivered over 20 conference presentations.

Questa Capital

Aabed Meer, Partner, Questa Capital

Aabed Meer, MD is a Partner at Questa Capital focused on growth-stage healthcare technology, healthcare services, and medical device investments. Investments that he is currently involved with include Bicycle Health, Claritas Rx, and Vynca. His prior investments include, Epic Systems, Altruista Health (acquired by Blackstone), HealthPlan Services (acquired by Wipro), Performance Health (acquired by Patterson Medical), AAI Pharma (acquired by CML/Alcami), and Breg. Previously, he was a Director and member of the founding team at Martis Capital, where he focused on private equity investments in the healthcare sector. Prior to that, he was with Capricorn Investment Group and New Enterprise Associates. Early in his career, he contributed to the Human Genome Project, an international research effort led by the National Institutes of Health. He also worked on health economics and policy matters at Kaiser Permanente and the U.K.’s National Health Service. He graduated from Harvard University with an AB in Biochemical Sciences, and from Stanford University with an MD and MBA. He completed his medical residency training at Stanford University and continues to serve as a Clinical Assistant Professor.

Komodo Health

Arif Nathoo, MD, Co-Founder & CEO, Komodo Health

Arif Nathoo, M.D., is the CEO and Co-Founder of Komodo Health, a healthcare technology company focused on reducing the burden of disease with data-driven insights and powerful software applications. Komodo believes the key to tackling healthcare's biggest challenges is the ability to transform extraordinary amounts of data into rich and meaningful insights. The company combines the world’s most comprehensive view of patient-encounters with innovative algorithms and decades of clinical expertise to power its Healthcare Map™. Founded in 2014, Komodo Health is backed by leading investors, including Tiger Global, Casdin Capital, ICONIQ, Andreessen Horowitz, Oak HC/FT, IA Ventures, Felicis Ventures, and McKesson Ventures. Previously, Arif was a leader in the Medical Affairs practice at McKinsey & Company, working to improve non-promotional scientific engagement between industry and providers. He holds an M.D. from Harvard Medical School and an A.B. in neurobiology from Harvard College.


Kal Patel, MD, Co-Founder & CEO, BrightInsight

Before joining BrightInsight, Kal was CCO for Doctor on Demand, founded and led Amgen’s Digital Health Business Unit and was also the Global Marketing Lead for Amgen’s Enbrel™. He also held various Commercial Leadership roles at Novartis, was a Principal with the Boston Consulting Group (BCG) and also served as a Senior Advisor in Digital Health to BCG. Kal holds an MD, MBA and BA from the University of Chicago.

Kristina Saffran, Co-Founder & CEO, Equip

Kristina Saffran is the cofounder and CEO of Equip, a virtual program that delivers modern eating disorder treatment through family-based care that promises lasting recovery at home. Prior to Equip, Kristina founded Project HEAL, a leading grassroots eating disorder non-profit dedicated to treatment access. Kristina is an Ashoka Fellow, a Forbes 30 under 30 social entrepreneur, and an honoree on both Inc’s Female Founders 100 and INSIDER’s 30 under 40 in Healthcare recognition lists. Kristina graduated from Harvard College with a bachelor's degree in psychology.

HCA Healthcare

Michael Schlosser, MD, MBA, Senior Vice President, Care Transformation and Innovation, HCA Healthcare

Dr. Schlosser's current position is Senior Vice President Care Transformation and Innovation for HCA Healthcare. In this role he leads clinical and care innovation and transformation for the enterprise. He is tasked with establishing and leading a new department within HCA Healthcare’s Clinical Operations Group (called Care Transformation & Innovation). The department’s vision is to redesign Models of Care within our acute care facilities focusing on digitally enabled, patient centered, and highly efficient care delivery. This includes partnering with Information Technology leadership on HCA’s Digital Transformation strategy and with Google’s cloud computing team to provided leadership and the development of a Digital Intelligence Net. Prior to this role he served as Chief Medical Officer for the HCA National Group, overseeing clinical operations for 105 acute care hospitals across 14 states and as Chief Medical Officer for HealthTrust, the group purchasing organization for 1600 hospitals nationwide. Dr. Schlosser practiced neurosurgery for 10 years prior to leaving practice to join HealthTrust. In his practice of neurosurgery, Dr. Schlosser specialized in spinal procedures including complex spine reconstruction for spinal deformity, tumors and infections. He completed residency and fellowship in neurosurgery at Johns Hopkins in 2005 and his MBA at the Vanderbilt Owen Graduate School of Management.

Josh Seidenfeld, JD, Partner, Cooley LLP

Josh Seidenfeld represents companies at all stages of their lifecycle, from startups to public companies with a focus on healthcare-related technology companies (both consumer and enterprise). He has represented issuers and underwriters in public offerings, has substantial experience representing both buyers and sellers in M&A and both issuers and investors in private company financings. Josh also regularly advises his clients on general corporate issues, securities matters and implications of proposed business transactions. Josh is a contributing editor of Cooley GO, an online resource with tools, forms, guidance and data for entrepreneurs and emerging companies. Over the past two years, Josh has advised his clients in 100+ private/public financings and 30 mergers, acquisitions, spinoffs or asset sale transactions. Prior to joining Cooley, Josh held several operating roles with early stage pre-revenue startups to multinational organizations. Most recently, he served as director of business development, strategic initiatives and corporate counsel for Practice Fusion, a venture-backed healthcare IT company. He holds a JD from Santa Clara University School of Law, an MBA from Santa Clara University Leavey School of Business and a BS, magna cum laude, from University of California, Riverside.

7wire Ventures

Lee Shapiro, JD, Managing Partner, 7wire Ventures

Lee Shapiro is Managing Partner at 7wireVentures. He also served as Chief Financial Officer of Livongo Health [NASDAQ:LVGO] until November 2020. During his tenure as CFO, Livongo also had a successful secondary offering, raised $550M in convertible debt, and entered into an agreement to merge at the highest valuation, $18.5B, of any healthcare technology company, based on revenue multiples. The price of $159 per share was over six times the price of Livongo’s shares at the time of its IPO, just 12 months earlier. Lee serves on the boards of The American Heart Association, where he is treasurer and serves on the business operations committee; Senior Connect, a special purpose acquisition company, Click Therapeutics, and serves on the board and committees of various 7wireVentures portfolio companies. He is also a co-founder and board member of The World Innovation Network and the advisory committee of the University of Chicago Innovation Fund.

Mona Siddiqui, MD, Senior Vice President for Enterprise Clinical Strategy and Quality, Humana

Mona Siddiqui, MD, MPH, MSE is Senior Vice President for Enterprise Clinical Strategy and Quality at Humana where she leads the development and management of Humana’s integrated clinical strategy and provides strategic direction for clinical quality in an effort to improve the quality of care and safety for patients. Dr. Siddiqui previously worked at the U.S. Department of Health and Human Services (HHS) where she served as the Department’s inaugural Chief Data Officer. In that role, she led the effort to connect the nation’s health care data through the build-out of an enterprise wide data-sharing platform and governance structure at HHS and advanced the Department’s Artificial Intelligence strategy. Previously, Dr. Siddiqui served at the Centers for Medicare and Medicaid Innovation working towards implementing rapid cycle testing for payment models. She has also served with the White House Social and Behavioral Sciences Team (“nudge” unit) during the Obama administration. Prior to her work in the federal government, Dr. Siddiqui was at the Johns Hopkins University Health System where she was focused on driving value based care initiatives. Dr. Siddiqui holds a Medical Degree from the Johns Hopkins University School of Medicine, a Master’s degree in Quantitative Methods from the Harvard School of Public Health, and a Master’s degree in Management and Engineering from the Stanford University School of Engineering.


Mandira Singh, Senior Vice President, General Manager, Acute & Payer Markets, PointClickCare

Mandira Singh brings more than a decade of experience to building and scaling leading companies in healthcare technology. Mandira currently serves as SVP and General Manager for the Acute & Payer business at PointClickCare, where she serves on the Executive Leadership Team and is focused on driving growth and delivering results for over a thousand hospitals and every national health plan in the U.S. Mandira joined PointClickCare via the acquisition of Collective Medical in December 2020, where she served as Chief Operating Officer. Prior to joining Collective, Mandira was Executive Director of Product, Platform at athenahealth, where she built athenahealth’s API-driven platform and created the industry’s leading developer experience. Previously, Mandira ran athenahealth’s More Disruption Please business unit including the athena Marketplace, which she grew from an initial business plan to a profitable business unit delivering more than 200 innovative apps to athena clients. Prior to joining athenahealth, Mandira was an investment professional at Essex Woodlands, a growth equity and venture capital firm focused on healthcare. Mandira started her career at J.P. Morgan, where she worked in the North America Healthcare Coverage Group and then the Private Equity Co-Investing group in New York. Mandira holds a BA in Economics from Vassar College and an MBA from the Stanford Graduate School of Business.

Stephen Smith, Co-Founder & CEO, NOCD, Inc.

Stephen Smith is the Cofounder and CEO of NOCD, the largest telehealth provider focused exclusively on ending the suffering caused by OCD worldwide. After emerging from a personal struggle with undiagnosed OCD, and experiencing the success of Exposure & Response Prevention (ERP) therapy first-hand, Stephen made it his mission to transform the behavioral health treatment system with the goal to create an anytime, anywhere virtual care platform that allows those suffering to be diagnosed quickly and accurately, and treated appropriately using ERP therapy - considered the gold standard for OCD treatment. Smith has ensured that evidence-based OCD Treatment can be insurance-covered, demonstrated by NOCD managing over 130 million covered lives today in the U.S. Smith was also named to the 2021 Forbes 30 under 30 in Healthcare List and to the 2020 Crain's Notable Entrepreneur List for his work in scaling NOCD.

SVB Securities

Jon Swope, Senior Managing Director, Head of Digital Health Investment Banking, Silicon Valley Bank

Jon Swope is a Senior Managing Director in Investment Banking at SVB Securities and leads the firm’s Digital Health and HealthTech practice. He also covers Managed Care and Payor Services companies. With over 12 years of healthcare investment banking experience, Mr. Swope has worked extensively with both private and publicly listed firms on mergers & acquisitions, equity offerings (IPOs, follow-ons and private placements), acquisition financings and debt financings. Mr. Swope joined SVB Securities in 2021 from Bank of America, most recently as Managing Director in the Global Healthcare Investment Banking Group. His prior work experience includes positions at Greenhill & Co., Bain & Company, and WTW. Mr. Swope holds a BA (cum laude) from Duke University and an MBA from Duke University’s Fuqua School of Business.

Everly Health

Julia Cheek, Founder & CEO, Everly Health


Sara Vaezy, Executive Vice President, Chief Strategy and Digital Officer, Providence

Sara Vaezy is Executive Vice President and Chief Strategy and Digital Officer for Providence where she is responsible for system strategy and digital innovation for the integrated delivery network (IDN) which includes 52 hospitals and 1,085 clinics and serves over 5 million unique patients. Sara is the architect of the corporate strategy and digital Innovation model at Providence. The model has generated technology collaborations and the successful commercialization of three incubated technologies into new companies. She’s a thought leader for digital innovation, and her framework for building and maintaining deep organizational relationships with stakeholders across the industry has resulted in partnerships with over 150 health system digital and innovation teams, venture capital organizations, industry analysts and influencers, and digital health organizations. Sara is active in the broader healthcare industry serving as an NCQA Board Director, a Harvard Executive Education Faculty Member, a Health Evolution Forum Fellow, a Forbes Business Council Member, and a board observer for DexCare. She holds an MHA and an MPH in Health Policy from the University of Washington School of Public Health and BAs in Physics and Philosophy from the University of California, Berkeley.

Julie Yoo, General Partner, a16z

Julie Yoo is a General Partner at Andreessen Horowitz where she leads investments in healthcare technology, with a focus on companies that are modernizing how we access, pay for, and experience the healthcare system. Prior to joining a16z, Julie was the co-founder, Chief Product Officer, and Board Director at Kyruus, a venture-backed healthtech company recognized as a market leader in patient access. Julie led product management, engineering, and sales and marketing for the company, and helped scale the business to reach 20M patients and over 225,000 healthcare providers across the U.S. Julie was previously VP of Product at Generation Health, and was with the company from its inception through acquisition by CVS Health. Julie was also a Product Manager at Knome, the world's first whole genome sequencing service for private individuals. Julie’s tech career began as an early member of the software engineering team at Endeca Technologies, which was acquired by Oracle. Julie studied computer science and pre-medicine as an undergrad at MIT and obtained an MS in genomics from Harvard-MIT HST and an MBA from MIT Sloan. Julie is a Young Global Leader with the World Economic Forum and has been recognized through numerous awards and honors from Becker’s Hospital Review, Health Data Management, MedTech Boston, and Rock Health. Julie serves on a number of portfolio company boards, including AKASA, Bayesian Health, Firefly Health, Ribbon Health, Tomorrow Health, and Zus Health.

American Telemedicine Association

Kyle Zebley, Senior Vice President, Public Policy, American Telemedicine Association

Kyle Zebley is Senior Vice President of Public Policy at the American Telemedicine Association (ATA) and Executive Director of ATA Action. He is working with and on behalf of ATA and ATA Action members and like-minded organizations to eliminate barriers to the expansion of telehealth and ensure patients, providers, and payers can realize the benefits of virtual care. Previously, Kyle was the Chief of Staff in the Office of Global Affairs (OGA) at the U.S. Department of Health and Human Services (HHS). He collaborated with senior leadership from HHS, the White House, and other cabinet departments to develop, advise, and promote U.S. global health policy, including in such policy areas as drug pricing, global health security, medical devices, and non-communicable diseases. Prior to HHS, he worked in Congress as a Legislative Director, leading a legislative team in developing policy and drafting legislation, particularly on matters concerning the House Committee on the Budget, the House Committee on Education and the Workforce, and the House Committee on Ways and Means. Kyle started his career in Washington, D.C. as a Research Assistant at Public Opinion Strategies, where he worked on campaign strategies for clients running for U.S. President, U.S. Senate, the U.S. House of Representatives, state governor, and state legislatures. Kyle is a sought-after policy expert. He has contributed his time to organizations developing model health policies, such as the Federation of State Medical Boards Workgroup on Telemedicine, the Uniform Law Commission Uniform Telehealth Act, and the World Health Organization Independent High-level Commission on Noncommunicable Diseases. Kyle is frequently quoted in major media coverage on the topic of telehealth, including the Associated Press, Bloomberg, Inside Health Policy, Kaiser Health News, Modern Healthcare, NBC news affiliates, NPR, Roll Call, Time, USA Today, the Wall Street Journal, and Yahoo! Finance. In early 2022, Kyle was named by Politico as one of the “Four Washington players poised to shape digital health in 2022”.


Ashwini Zenooz, MD, CEO, Commure

Ashwini Zenooz, MD is the CEO of Commure. A board-certified radiologist, Dr. Zenooz has more than 20 years of clinical experience and has held leadership roles across the public and private sectors. At Salesforce, she was Chief Medical Officer and GM of Global Healthcare and Life Sciences. She served as Chief Medical Officer at the Department of Veterans Affairs overseeing the EHR modernization program. She has also held senior policy roles including serving as Brookings Legislative Health Policy Fellow with U.S. Senator Richard Blumenthal, and U.S. Senate Committee Staff. Dr. Zenooz received her MD in the Medical Honors Program at the University of Florida, completed her radiology residency at Henry Ford Health System, and an Abdominal Imaging fellowship at Massachusetts General Hospital.